Optimal Time-to-Surgery for Patients with Esophageal Cancer after Neoadjuvant Chemoradiotherapy

被引：0
|
作者：
Wang, Qifeng [1 ,2 ]
Li, Jingqiu [1 ,2 ]
Zhou, Xiaoding [1 ,2 ]
Liu, Ying [1 ,2 ]
Zhu, Jie [1 ,2 ]
Leng, Xuefeng [3 ]
Peng, Lin [3 ]
Han, Yongtao [3 ]
机构：
[1] Sichuan Canc Ctr, Radiat Oncol, Chengdu, Peoples R China
[2] Radiat Oncol Key Lab, Chengdu, Sichuan, Peoples R China
[3] Sichuan Canc Ctr, Thorac Surg, Chengdu, Peoples R China
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
ESCC; NCRT; tumor regression; time to surgery; TUMOR VOLUME CHANGE; PROLONGED-TIME; CHEMORADIATION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
434
引用
收藏
页码：S2143 / S2146
页数：5
相关论文
共 50 条
  • [31] Neoadjuvant Chemotherapy or Chemoradiotherapy for Locally Advanced Esophageal Cancer
    Smithers, B. Mark
    Thomson, Iain
    THORACIC SURGERY CLINICS, 2013, 23 (04) : 509 - +
  • [32] The influence of time-to-surgery on mortality after a hip fracture
    Kristiansson, Johan
    Hagberg, Eva
    Nellgard, Bengt
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2020, 64 (03) : 347 - 353
  • [33] Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer
    Borggreve, Alicia S.
    Heethuis, Sophie E.
    Boekhoff, Mick R.
    Goense, Lucas
    van Rossum, Peter S. N.
    Brosens, Lodewijk A. A.
    van Lier, Astrid L. H. M. W.
    van Hillegersberg, Richard
    Lagendijk, Jan J. W.
    Mook, Stella
    Ruurda, Jelle P.
    Meijer, Gert J.
    EUROPEAN RADIOLOGY, 2020, 30 (04) : 1896 - 1907
  • [34] Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients
    Mei, Shi-Wen
    Liu, Zheng
    Wei, Fang-Ze
    Chen, Jia-Nan
    Wang, Zhi-Jie
    Shen, Hai-Yu
    Li, Juan
    Zhao, Fu-Qiang
    Pei, Wei
    Wang, Zheng
    Wang, Xi-Shan
    Liu, Qian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (31) : 4624 - 4638
  • [35] Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Implications for the Extent of Lymphadenectomy
    Robb, William B.
    Maillard, Emilie
    Mariette, Christophe
    ANNALS OF SURGERY, 2017, 266 (06) : E53 - E54
  • [36] Surgery or Surveillance for Esophageal Squamous Cell Carcinoma With Clinical Complete Response After Neoadjuvant Chemoradiotherapy
    Ting, Ying-Che
    Hsu, Po-Kuei
    Chen, Hui-Shan
    Lin, Chih-Hung
    Chuang, Cheng-Yen
    Hsu, Han-Shui
    Hsu, Chung-Ping
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (03) : 603 - 614
  • [37] Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer
    Shapiro, Joel
    Biermann, Katharina
    van Klaveren, David
    Offerhaus, G. Johan A.
    ten Kate, Fiebo J. W.
    Meijer, Sybren L.
    Henegouwen, Mark I. van Berge
    Steyerberg, Ewout W.
    Wijnhoven, Bas P. L.
    van Lanschot, J. Jan B.
    ANNALS OF SURGERY, 2017, 265 (02) : 356 - 362
  • [38] Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients
    Dijksterhuis, Willemieke P. M.
    Hulshoff, Jan Binne
    van Dullemen, Hendrik M.
    Kats-Ugurlu, Gursah
    Burgerhof, Johannes G. M.
    Korteweg, Tijmen
    Mul, Veronique E. M.
    Hospers, Geke A. P.
    Plukker, John T. M.
    ACTA ONCOLOGICA, 2019, 58 (11) : 1640 - 1647
  • [39] Different accuracy of endosonographic tumor staging after neoadjuvant chemotherapy and chemoradiotherapy in esophageal cancer
    Bohle, Wolfram
    Kasper, Michaela
    Zoller, Wolfram G.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (07): : 2922 - 2928
  • [40] Survival and complications after neoadjuvant chemotherapy or chemoradiotherapy for esophageal cancer: a meta-analysis
    Han, Jinmin
    Wang, Zhongtang
    Liu, Chengxin
    FUTURE ONCOLOGY, 2021, 17 (17) : 2257 - 2274
12345